Recombinant IL-6 treatment protects mice from organ specific autoimmune disease by IL-6 classical signalling-dependent IL-1ra induction
Keywords: اینترلوکین ۶; Autoimmunity; Autoantibodies; Interleukin-6; Epidermolysis bullosa acquisita; Bullous diseasesIL-1, Interleukin-1; IL-1ra, Interleukin 1 receptor antagonist; IL-6, interleukin-6; IL-4, Interleukin-4; IL-10, Interleukin-10; TGF-β, Transforming growth facto